Production of hemopexin by TNF-α stimulated human mesangial cells

Kidney International

Volumn 63, Issue 5, 2003, Pages 1681-1686

  Kapojos, Jola J ^b   Van Den Berg, Anke ^b   Van Goor, Harry ^b   Te Loo, Maroeska W M ^b   Poelstra, Klaas ^b   Borghuis, Theo ^b   Bakker, Winston W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Corticosteroid responsive nephrotic syndrome; Hemopexin; Inflammation; Mesangium; Prednisolone; TNF

Indexed keywords

CORTICOSTEROID; HEMOPEXIN; IMMUNOGLOBULIN G; MESSENGER RNA; MONOCLONAL ANTIBODY; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MESANGIUM CELL; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0242669259     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00907.x     Document Type: Article

References (36)

1. MULLER-EBERHARD U: Hemopexin. Methods Enzymol 163:536-565, 1988
2. KUZELOVA K, MRHALOVA M, HRKAL Z: Kinetics of heme interaction with heme-binding proteins: The effect of heme aggregation state. Biochim Biophys Acta 1336:497-501, 1997
3. TAKETANI S, IMMENSCHUH S, GO S, et al: Hemopexin from four species inhibits the association of heme with cultured hepatoma cells or primary rat hepatocytes exhibiting a small number of species specific hemopexin receptors. Hepatology 27:808-814, 1998
4. BALLA G, VERCELLOTTI GM, MULLER-EBERHARD U, et al: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64:648-655, 1991
5. CAMBORIEUX L, BERTRAND N, SWERTS JP: Changes in expression and localization of hemopexin and its transcripts in injured nervous system: A comparison of central and peripheral tissues. Neuroscience 82:1039-1052, 1998
6. HUNT RC, HUNT DM, GAUR N, SMITH A: Hemopexin in the human retina: Protection of the retina against heme- mediated toxicity. J Cell Physiol 168:71-80, 1996
7. CHEN W, LU H, DUTT K, et al: Expression of the protective proteins hemopexin and haptoglobin by cells of the neural retina. Exp Eye Res 67:83-93, 1998
8. SWERTS JP, SOULA C, SAGOT Y, et al: Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy. J Biol Chem 267:10596-10600, 1992
9. MADORE N, CAMBORIEUX L, BERTRAND N, SWERTS JP: Regulation of hemopexin synthesis in degenerating and regenerating rat sciatic nerve. J Neurochem 72:708-715, 1999
10. CAMBORIEUX L, JULIA V, PIPY B, SWERTS JP: Respective roles of inflammation and axonal breakdown in the regulation of peripheral nerve hemopexin: An analysis in rats and in C57BL/Wlds mice. J Neuroimmunol 107:29-41, 2000
11. TOLOSANO E, HIRSCH E, PATRUCCO E, et al: Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. Blood 94:3906-3914, 1999
12. CHEUNG PK, STULP B, IMMENSCHUH S, et al: Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 10:1700-1708, 1999
13. CHEUNG PK, KLOK PA, BALLER JF, BAKKER WW: Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57:1512-1520, 2000
14. BAKKER WW, BALLER JF, VAN LUIJK WH: A kallikrein-like molecule and plasma vasoactivity in minimal change disease. Increased turnover in relapse versus remission. Contrib Nephrol 67:31-36, 1988
15. MOHOS SC, SKOZA L: Histochemical demonstration and localization of sialoproteins in the glomerulus. Exp Mol Pathol 12:316-323, 1970
16. VAN SETTEN PA, VAN HINSBERGH VW, VAN DEN HEUVEL LP, et al: Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: Evidence for two distinct mechanisms. J Am Soc Nephrol 8:1877-1888, 1997
17. WARNKE R, LEVY R: Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28:771-776, 1980
18. KOVALOVSKY D, REFOJO D, HOLSBOER F, ARZT E: Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol 109:23-29, 2000
19. SCHIMMER BP, PARKER KL: Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., edited by HARDMAN JG, GOODMAN GILMAN A, LIMBIRD LE, New York, McGraw-Hill Co., 1996, pp 1459-1485
20. CHROUSOS GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362, 1995
21. BAUMANN H, GAULDIE J: The acute phase response. Immunol Today 15:74-80, 1994
22. BAUMANN H, JAHREIS GP, GAINES KC: Synthesis and regulation of acute phase plasma proteins in primary cultures of mouse hepatocytes. J Cell Biol 97:866-876, 1983
23. CAMPOS SP, WANG Y, KOJ A, BAUMANN H: Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells. J Immunol 151:7128-7137, 1993
24. BAUMANN H, JAHREIS GP, SAUDER DN, KOJ A: Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J Biol Chem 259:7331-7342, 1984
25. EASTMAN HB, FAWCETT TW, UDELSMAN R, HOLBROOK NJ: Effects of perturbations of the hypothalamic-pituitary-adrenal axis on the acute phase response: Altered C/EBP and acute phase response gene expression in lipopolysaccharide-treated rats. Shock 6:286-292, 1996
26. MARINKOVIC S, JAHREIS GP, WONG GG, BAUMANN H: IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808-812, 1989
27. TAPPEL AL: Unsaturated lipid oxidation catalyzed by hematin compounds. J Biol Chem 217:721-733, 1955
28. VINCENT SH: Oxidative effects of heme and porphyrins on proteins and lipids. Semin Hematol 26:105-113, 1989
29. AFT RL, MUELLER GC: Hemin-mediated DNA strand scission. J Biol Chem 258:12069-12072, 1983
30. GRACA-SOUZA AV, ARRUDA MA, DE FREITAS MS, et al: Neutrophil activation by heme: implications for inflammatory processes. Blood 99:4160-4165, 2002
31. SHIPULINA N, HUNT RC, SHAKLAI N, SMITH A: Coordination of nitric oxide by heme-hemopexin. J Protein Chem 17:255-260, 1998
32. CATTELL V: Nitric oxide and glomerulonephritis. Kidney Int 61:816-821, 2002
33. KETTELER M, WESTENFELD R, GAWLIK A, et al: Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritis. Kidney Int 61:826-833, 2002
34. SHALHOUB RJ: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556-560, 1974
35. SAVIN VJ: Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347-362, 1993
36. SAHALI D, PAWLAK A, VALANCIUTE A, et al: A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238-1247, 2002